Catechol

Catechol

SCHEMBL2781528

O=C1CSC(=S)N1.Oc1ccccc1O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 2/20 0.67
▸ GSK3B P49841 2/20 0.67
▸ NAT1 P18440 2/20 0.44
▸ MAOA P21397 2/20 0.42
▸ MAOB P27338 2/20 0.42
▸ ALOX15 P16050 3/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ HPGD P15428 4/20 0.41
▸ TDP1 Q9NUW8 3/20 0.41
▸ USP2 O75604 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ MGAM O43451 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ SI P14410 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MAPT P10636 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Catechol SCHEMBL3758856 0.92 GSK3A (0.56) GSK3AGSK3BNAT1MAOAMAOB
Rhodanine SCHEMBL2229918 0.82 GSK3A (1.00) GSK3AGSK3BMAOAMAOBHPGD
Rhodanine SCHEMBL55625 0.82 — —
Rhodanine SCHEMBL94126 0.82 — —
Rhodanine SCHEMBL3758858 0.81 GSK3A (0.47) GSK3AGSK3BNAT1ALOX15PTGS2
Rhodanine SCHEMBL8017015 0.80 — —
Rhodanine SCHEMBL5919491 0.80 — —
Rhodanine SCHEMBL2403229 0.80 — —
Rhodanine SCHEMBL38654015 0.80 — —
Rhodanine SCHEMBL11436580 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010141596-A2 CHEMICAL PROTEOMIC ASSAY FOR OPTIMIZING DRUG BINDING TO TARGET PROTEINS MARQUETTE UNIVERSITY (US) 2010-12-09 — — WO disclosed
US-20100304998-A1 Chemical Proteomic Assay for Optimizing Drug Binding to Target Proteins MARQUETTE UNIVERSITY (US) 2010-12-02 — — US disclosed
Send feedback